Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo - A specific vascular action of insulin

Circulation

Volumn 101, Issue 6, 2000, Pages 676-681

  Kuboki, Koji ^a   Jiang, Zhen Y ^a   Takahara, Noriko ^a   Ha, Sung Woo ^a   Igarashi, Masahiko ^a   Yamauchi, Teruaki ^a   Feener, Edward P ^a   Herbert, Terrance P ^a   Rhodes, Christopher J ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Cells; Diabetes mellitus; Endothelium; Insulin; Nitric oxide; Proteins; RNA

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; INSULIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CATTLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONE ACTION; INSULIN RESISTANCE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 0034651949     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.6.676     Document Type: Article

References (28)

1. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet. 1997;350(suppl 1):SI9-SI13.
2. Scherrer U, Sartorio C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular mortality. Circulation. 1997;96:4104-4113.
3. Baron AD, Brechtel-Hook C, Johnson A, Cronin J, Learning R, Steinberg HO. Effect of perfusion rate on the time course of insulin mediated skeletal muscle glucose uptake. Am J Physiol. 1996;271:E1067-E1072.
4. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilation: physiology or pharmacology? Diabetologia. 1998;41:369-379.
5. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94: 1172-1179.
6. Utriainen T, Makimattila S, Virkamaki A, Bergholm R, Yki-Jarvinen H. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia. 1996;39:1477-1482.
7. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
8. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest. 1997;100:2146-2152.
9. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;100:2417-2423.
10. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem. 1992;267:6370-6374.
11. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347:768-770.
12. Xia P, Aiello LP, Ishii H, Jiang Z, Park DJ, Robinson GS, Takagi H, Jirousek M, Newsome WP, King GL. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996;98:2018-2026.
13. Okada T, Sakuma L, Fukui Y, Hazeki O, Ui M. Blockage of chemotactic peptide induced stimulation if neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J Biol Chem. 1994; 269:3563-3567.
14. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 1994;14:4902-4911.
15. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Jakanes M, Baudet V, Boissin P, Boursier E, Loriolle F. The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
16. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science. 1996;272:728-731.
17. Becker TC, Noel RJ, Coats WS, Gomez-Foix, Alam T, Gerard RD, Newgard CB. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 1994;43:161-189.
18. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209.
19. Wakasaki H, Koya D, Schoen F, Jirousek M, Ways DK, Hoit BD, Walsh RA, King GL. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A. 1997; 94:9320-9325.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
21. Ohara Y, Sayegh H, Yamin JJ, Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension. 1995;25:415-420.
22. White MF. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res. 1998;53: 119-138.
23. Shimabukuro M, Zhou YT, Lee Y, Unger RH. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem. 1998;273:3547-3550.
24. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 1994;45:598-604.
25. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Physiol Rev. 1996;76:1109-1161.
26. Kent KC, Mii S, Harrington EO, Chang JD, Mallette S, Ware JA. Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation. Circ Res. 1995;77: 231-238.
27. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47:859-866.
28. Young ME, Leighton B. Evidence for altered sensitivity of the nitric oxide/cGMP-signaling cascade in insulin-resistant skeletal muscle. Biochem J. 1998;329:73-79.